Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / W••• P••••••

I•••••• Partners with W••• P••••••

Platform acquisitionclosedannounced Jun 23, 2026closed Jun 23, 2026Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
business_services / testing
Target location
GA, US
Seller kind
Founder
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • N•• M••••••Deal partnerconfirmed
    “Under G••••’s leadership, W••• P•••••• has become a premier scaled service provider in a highly fragmented industry,” said N•• M••••••, Managing Director at I••••••.
  • I•••••• E••••• P••••••• (“I••••••”), a leading private equity firm dedicated to investing across the middle market, is pleased to announce its partnership with W••• P•••••• (“W••• P••••••” or the “Company”), a provider of medical and health physics testing and consulting services.
Side not stated
  • Dr. G•••• W•••, Founder and CEO of W••• P••••••, noted: “LNC has been a valuable partner to W••• P••••••, providing strategic support and flexible capital that helped us expand our capabilities, grow our team, and continue delivering exceptional service and trusted expertise to our customers.
  • I•••••• Partners with W••• P••••••
Evidence
I•••••• Partners with W••• P••••••
I•••••• Partners with W••• P•••••• | Private Equity Intelligence | DFX